Skip to Main

Search

Results 351 to 360 of 1,043 for ""

UTSW study examines off-label drugs prescribed in addition to insulin for Type 1 diabetes: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-type-1-diabetes.html

Two classes of drugs prescribed off-label for some patients with Type 1 diabetes can provide significant benefits but also come with health concerns, according to a study by UT Southwestern Medical Center researchers.

"Reelin" in a new treatment for multiple sclerosis: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/new-treatment-ms.html

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease’s characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Brinster Prize

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-brinster-prize.html

Zhijian “James” Chen, Ph.D., Professor in the Department of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on innate immunity, has been awarded the 2026 Elaine Redding Brinster Prize in Science or Medicine.

Newsroom Archive: 2024 - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/

Stories published in 2024 about UT Southwestern Medical Center.

New CEO to lead UTSW’s Clements University Hospital: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-cuh-ceo.html

Traci d’Auguste, M.B.A., M.S.H.A., who has more than two decades of leadership experience in academic medicine, is the new Vice President and Chief Executive Officer of UT Southwestern Medical Center’s William P. Clements Jr. University Hospital (CUH), effective today.

Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-semaglutide.html

Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows.

Athletes can rest easy: Extreme exercise does not raise heart disease risk or mortality: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/extreme-exercise.html

High volumes of exercise are safe, even when coronary calcium levels are high.

Can timing of food affect lifespan?: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/timing-of-food-lifespan.html

Dr. Joseph Takahashi, noted for discovering the first gene controlling biological clocks in mammals, addressed the topic at the Society for Neuroscience annual meeting where he was awarded the Gruber Neuroscience Prize for his pioneering work in circadian rhythms.

2019 Match Day Specialty List: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/match-day-specialty.html

Grouped by specialty, here are the matches achieved by members of the UT Southwestern Medical School Class of 2019.

Hypnosis through virtual reality aids in medical recovery: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/virtual-reality.html

Anesthesiologists are exploring the use of hypnosis through virtual reality to lessen postoperative pain and anxiety in children.